Search Results

10 results for public health genomics

Genomic Tests and Population Health: An Online Catalog to Promote a Conversation on Evolving Evidence

stacked boxed with A T C G on them

  With the rapid emergence of genomic tests, healthcare providers, patients and policy makers need to know how useful they are and whether the benefits of their use outweigh potential harms to patients, families, and the population. CDC’s Office of Public Health Genomics now offers a list of health-related genomic tests and applications, stratified into

Posted on by Muin J Khoury, Director, Office of Public Health Genomics, Centers for Disease Control and Prevention4 CommentsTags , , , , ,

Ushering Public Health Practice into the 21st Century

Public Health Genomics

The April 2012  special issue of the journal Public Health Genomics includes 13 articles from the many presentations at the 4th National Conference on Genomics and Public Health in the United States: “Using Genetic Information to Improve Health Now and In the Future”.  The three-day conference sponsored by the Centers for Disease Control and Prevention, 

Posted on by Muin J Khoury, Director, Office of Public Health Genomics, Centers for Disease Control and PreventionTags , ,

The Public Health Approach to Genetic Testing in the 21st Century: Saving Lives and Saving Unnecessary Healthcare Costs

vials on top of money

In March 2012, a prominent health insurer in the United States released a white paper entitled: “Personalized Medicine: trends and prospects for the new science of genetic testing and molecular diagnostics” By analyzing their own claims data, the report suggests that in 2010, the cost of genetic and molecular diagnostic testing for its members was about $500

Posted on by Muin J Khoury, Director, Office of Public Health Genomics, Centers for Disease Control and Prevention4 CommentsTags , , , ,

Beyond Base Pairs to Bedside: A Community Consultation on Closing the Gap between Genomic Discoveries and the Public’s Health

Priorities for Public Health Genomics 2012-2017

In June 2011, the CDC Office of Public Health Genomics launched a community wide consultation process to develop priorities for the field of public health genomics in the next 5 years. This process was initiated as part of strategic visioning for integrating the emerging tools of genomics into practice and assuring the success of these

Posted on by Muin J Khoury, Director, Office of Public Health Genomics, Centers for Disease Control and PreventionTags , ,

Can We have Our Genome and Eat It Too? Deploying the Whole Genome Sequence In Medicine and Public Health, One Base Pair At A Time.

cake with double helix decoration - text: One base pair at a time

This post was originally published November 3, 2011 but is still very much applicable in 2013! The popular proverbial saying “you cannot have your cake and eat it too”  implies that one cannot consume something and preserve it at the same time–in other words, we cannot have it both ways.  Well, for once, maybe we

Posted on by Muin J Khoury, Director, Office of Public Health Genomics, Centers for Disease Control and Prevention4 Comments

Think Before You Spit: Do Personal Genomic Tests Improve Health?

Think Before You Spit- a woman looking at a test tube

Campaigns against public spitting in the 19th century were largely driven by concerns about the spread of tuberculosis. However, at the beginning of the 21st century, spitting seems to be making a comeback.  Over the past few years, several companies have begun offering personal genomic tests online to the public. There have been famous images of

Posted on by Muin J Khoury, Director, Office of Public Health Genomics, Centers for Disease Control and Prevention11 CommentsTags , ,

New Blog: Genomics Matters

Genetics  has a role in diseases of public health significance that affect infants, children, and adults. Our genes influence our response to drugs, infectious threats, and environmental exposures. More than 2,000 genetic tests are in use today and many more are coming.   In spite of the rapid pace of discovery in genetics, we are still in

Posted on by Muin J Khoury, Director, Office of Public Health Genomics, Centers for Disease Control and Prevention43 CommentsTags ,

The Promise of Population-based Genomic Screening for Selected Hereditary Conditions: Contributions of Cost-Effectiveness Analysis

individuals connected with DNA and dollar bills in the background

It is estimated that 3 million people in the United States carry pathogenic variants that increase their risks for heart disease and cancer. If people with such variants are identified, medical interventions are available to significantly reduce morbidity and mortality. However, existing recommendations tend to emphasize family-based or ethnic-specific criteria to determine at-risk individuals for

Posted on by Nandana D. Rao, Lu Shi, Muin J. Khoury, Office of Genomics and Precision Public Health, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia1 CommentTags ,

Trends in Tier 1 Genomic Applications 2013-2022

two figures looking at genomics trends with the text Tier 1 Applications

The CDC Tier 1 genomic applications database can help consumers, providers, health care organizations and public health programs accelerate the translation of genomic discoveries into improved population health.       Background Advances in genomics and precision medicine are proceeding at a rapid pace. Many genomic tests have reached clinical practice without clear indication as to whether their

Posted on by Mindy Clyne, W. David Dotson, Muin J. Khoury, Office of Genomics and Precision Public Health, Centers for Disease Control and Prevention, Atlanta, GeorgiaTags ,

Tier 1 Guidelines on Family-Based Screening for Hereditary Hemochromatosis

Tier 1 Guidelines for Hereditary Hemochromatosis with a photo of a family with adult children

An important function in public health genomics is to identify evidence-based genomic applications that can save lives and prevent disease. In maintaining the PHGKB Tier Coded Guidelines database, we routinely look for Tier 1 applications of genomic testing strategies that have evidence-based guidance supporting implementation in specific clinical scenarios. We only consider recommendations that have

Posted on by W. David Dotson, Katherine Kolor, Muin J. Khoury, Office of Genomics and Precision Public Health, Office of Science; and Scott D. Grosse, National Center on Birth Defects and Developmental DisabilitiesTags ,